CDK5RAP3: Difference between revisions
Jump to navigation
Jump to search
m (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}})) |
m (Bot: HTTP→HTTPS) |
||
Line 1: | Line 1: | ||
{{Infobox_gene}} | |||
'''CDK5 regulatory subunit-associated protein 3''' is a [[protein]] that in humans is encoded by the ''CDK5RAP3'' [[gene]].<ref name="pmid10721722">{{cite journal | vauthors = Ching YP, Qi Z, Wang JH | title = Cloning of three novel neuronal Cdk5 activator binding proteins | journal = Gene | volume = 242 | issue = 1–2 | pages = 285–94 |date=Apr 2000 | pmid = 10721722 | pmc = | doi =10.1016/S0378-1119(99)00499-0 }}</ref><ref name="entrez">{{cite web | title = Entrez Gene: CDK5RAP3 CDK5 regulatory subunit associated protein 3| url = https://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=80279| accessdate = }}</ref> | |||
Neuronal CDC2-like [[kinase]], which is involved in the regulation of [[neuron]]al [[Cellular differentiation|differentiation]], is composed of a catalytic subunit, [[CDK5]], and an activating subunit, [[CDK5R1|p25NCK5A]]. The protein encoded by this gene binds to p25NCK5A and therefore may be involved in neuronal differentiation. The encoded protein, which may be a substrate of neuronal CDC2-like kinase, has also been found in vascular endothelial cells, where it mediates [[cell proliferation]].<ref name="entrez"/> | |||
==References== | |||
{{reflist}} | |||
==Further reading== | |||
{{refbegin | 2}} | |||
{{PBB_Further_reading | |||
| citations = | |||
*{{cite journal | vauthors=Maruyama K, Sugano S |title=Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides |journal=Gene |volume=138 |issue= 1–2 |pages= 171–4 |year= 1994 |pmid= 8125298 |doi=10.1016/0378-1119(94)90802-8 }} | |||
*{{cite journal | vauthors=Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K |title=Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library |journal=Gene |volume=200 |issue= 1–2 |pages= 149–56 |year= 1997 |pmid= 9373149 |doi=10.1016/S0378-1119(97)00411-3 |display-authors=etal}} | |||
*{{cite journal | vauthors=Wang X, Ching YP, Lam WH |title=Identification of a common protein association region in the neuronal Cdk5 activator |journal=J. Biol. Chem. |volume=275 |issue= 41 |pages= 31763–9 |year= 2000 |pmid= 10915792 |doi= 10.1074/jbc.M004358200 |display-authors=etal}} | |||
*{{cite journal | vauthors=Ching YP, Pang AS, Lam WH |title=Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor |journal=J. Biol. Chem. |volume=277 |issue= 18 |pages= 15237–40 |year= 2002 |pmid= 11882646 |doi= 10.1074/jbc.C200032200 |display-authors=etal}} | |||
*{{cite journal | vauthors=Chen J, Liu B, Liu Y |title=A novel gene IC53 stimulates ECV304 cell proliferation and is upregulated in failing heart |journal=Biochem. Biophys. Res. Commun. |volume=294 |issue= 1 |pages= 161–6 |year= 2002 |pmid= 12054757 |doi= 10.1016/S0006-291X(02)00446-1 |display-authors=etal}} | |||
*{{cite journal | vauthors=Strausberg RL, Feingold EA, Grouse LH |title=Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=99 |issue= 26 |pages= 16899–903 |year= 2003 |pmid= 12477932 |doi= 10.1073/pnas.242603899 | pmc=139241 |display-authors=etal}} | |||
*{{cite journal | vauthors=Xie YH, He XH, Tang YT |title=Cloning and characterization of human IC53-2, a novel CDK5 activator binding protein |journal=Cell Res. |volume=13 |issue= 2 |pages= 83–91 |year= 2003 |pmid= 12737517 |doi= 10.1038/sj.cr.7290153 |display-authors=etal}} | |||
*{{cite journal | vauthors=Ota T, Suzuki Y, Nishikawa T |title=Complete sequencing and characterization of 21,243 full-length human cDNAs |journal=Nat. Genet. |volume=36 |issue= 1 |pages= 40–5 |year= 2004 |pmid= 14702039 |doi= 10.1038/ng1285 |display-authors=etal}} | |||
*{{cite journal | vauthors=Cen H, Zheng S, Fang YM |title=Induction of HSF1 expression is associated with sporadic colorectal cancer |journal=World J. Gastroenterol. |volume=10 |issue= 21 |pages= 3122–6 |year= 2004 |pmid= 15457556 |doi= |display-authors=etal}} | |||
*{{cite journal | vauthors=Gerhard DS, Wagner L, Feingold EA |title=The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC) |journal=Genome Res. |volume=14 |issue= 10B |pages= 2121–7 |year= 2004 |pmid= 15489334 |doi= 10.1101/gr.2596504 | pmc=528928 |display-authors=etal}} | |||
*{{cite journal | vauthors=Jiang H, Luo S, Li H |title=Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint |journal=J. Biol. Chem. |volume=280 |issue= 21 |pages= 20651–9 |year= 2005 |pmid= 15790566 |doi= 10.1074/jbc.M413431200 }} | |||
*{{cite journal | vauthors=Yin X, Warner DR, Roberts EA |title=Novel interaction between nuclear co-activator CBP and the CDK5 activator binding protein - C53 |journal=Int. J. Mol. Med. |volume=16 |issue= 2 |pages= 251–6 |year= 2005 |pmid= 16012757 |doi= 10.3892/ijmm.16.2.251|display-authors=etal}} | |||
*{{cite journal | vauthors=Wang J, He X, Luo Y, Yarbrough WG |title=A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2 |journal=Biochem. J. |volume=393 |issue= Pt 2 |pages= 489–501 |year= 2006 |pmid= 16173922 |doi= 10.1042/BJ20050960 | pmc=1360699 }} | |||
*{{cite journal | vauthors=Kim E, Chen F, Wang CC, Harrison LE |title=CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation |journal=Int. J. Oncol. |volume=28 |issue= 1 |pages= 191–4 |year= 2006 |pmid= 16327995 |doi= 10.3892/ijo.28.1.191}} | |||
*{{cite journal | vauthors=Camargo LM, Collura V, Rain JC |title=Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia |journal=Mol. Psychiatry |volume=12 |issue= 1 |pages= 74–86 |year= 2007 |pmid= 17043677 |doi= 10.1038/sj.mp.4001880 |display-authors=etal}} | |||
*{{cite journal | vauthors=Ewing RM, Chu P, Elisma F |title=Large-scale mapping of human protein-protein interactions by mass spectrometry |journal=Mol. Syst. Biol. |volume=3 |issue= 1|pages= 89 |year= 2007 |pmid= 17353931 |doi= 10.1038/msb4100134 | pmc=1847948 |display-authors=etal}} | |||
*{{cite journal | vauthors=Stav D, Bar I, Sandbank J |title=Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma |journal=Int. J. Biol. Markers |volume=22 |issue= 2 |pages= 108–13 |year= 2007 |pmid= 17549666 |doi= }} | |||
*{{cite journal | vauthors=Wang J, An H, Mayo MW |title=LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB |journal=Cancer Cell |volume=12 |issue= 3 |pages= 239–51 |year= 2007 |pmid= 17785205 |doi= 10.1016/j.ccr.2007.07.002 |display-authors=etal}} | |||
}} | |||
{{refend}} | |||
==External links== | |||
* {{UCSC gene info|CDK5RAP3}} | |||
<!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | <!-- The PBB_Controls template provides controls for Protein Box Bot, please see Template:PBB_Controls for details. --> | ||
{{PBB_Controls | {{PBB_Controls | ||
Line 8: | Line 43: | ||
}} | }} | ||
{{ | {{gene-17-stub}} | ||
Latest revision as of 09:29, 30 August 2017
VALUE_ERROR (nil) | |||||||
---|---|---|---|---|---|---|---|
Identifiers | |||||||
Aliases | |||||||
External IDs | GeneCards: [1] | ||||||
Orthologs | |||||||
Species | Human | Mouse | |||||
Entrez |
|
| |||||
Ensembl |
|
| |||||
UniProt |
|
| |||||
RefSeq (mRNA) |
|
| |||||
RefSeq (protein) |
|
| |||||
Location (UCSC) | n/a | n/a | |||||
PubMed search | n/a | n/a | |||||
Wikidata | |||||||
|
CDK5 regulatory subunit-associated protein 3 is a protein that in humans is encoded by the CDK5RAP3 gene.[1][2]
Neuronal CDC2-like kinase, which is involved in the regulation of neuronal differentiation, is composed of a catalytic subunit, CDK5, and an activating subunit, p25NCK5A. The protein encoded by this gene binds to p25NCK5A and therefore may be involved in neuronal differentiation. The encoded protein, which may be a substrate of neuronal CDC2-like kinase, has also been found in vascular endothelial cells, where it mediates cell proliferation.[2]
References
- ↑ Ching YP, Qi Z, Wang JH (Apr 2000). "Cloning of three novel neuronal Cdk5 activator binding proteins". Gene. 242 (1–2): 285–94. doi:10.1016/S0378-1119(99)00499-0. PMID 10721722.
- ↑ 2.0 2.1 "Entrez Gene: CDK5RAP3 CDK5 regulatory subunit associated protein 3".
Further reading
- Maruyama K, Sugano S (1994). "Oligo-capping: a simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides". Gene. 138 (1–2): 171–4. doi:10.1016/0378-1119(94)90802-8. PMID 8125298.
- Suzuki Y, Yoshitomo-Nakagawa K, Maruyama K, et al. (1997). "Construction and characterization of a full length-enriched and a 5'-end-enriched cDNA library". Gene. 200 (1–2): 149–56. doi:10.1016/S0378-1119(97)00411-3. PMID 9373149.
- Wang X, Ching YP, Lam WH, et al. (2000). "Identification of a common protein association region in the neuronal Cdk5 activator". J. Biol. Chem. 275 (41): 31763–9. doi:10.1074/jbc.M004358200. PMID 10915792.
- Ching YP, Pang AS, Lam WH, et al. (2002). "Identification of a neuronal Cdk5 activator-binding protein as Cdk5 inhibitor". J. Biol. Chem. 277 (18): 15237–40. doi:10.1074/jbc.C200032200. PMID 11882646.
- Chen J, Liu B, Liu Y, et al. (2002). "A novel gene IC53 stimulates ECV304 cell proliferation and is upregulated in failing heart". Biochem. Biophys. Res. Commun. 294 (1): 161–6. doi:10.1016/S0006-291X(02)00446-1. PMID 12054757.
- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Xie YH, He XH, Tang YT, et al. (2003). "Cloning and characterization of human IC53-2, a novel CDK5 activator binding protein". Cell Res. 13 (2): 83–91. doi:10.1038/sj.cr.7290153. PMID 12737517.
- Ota T, Suzuki Y, Nishikawa T, et al. (2004). "Complete sequencing and characterization of 21,243 full-length human cDNAs". Nat. Genet. 36 (1): 40–5. doi:10.1038/ng1285. PMID 14702039.
- Cen H, Zheng S, Fang YM, et al. (2004). "Induction of HSF1 expression is associated with sporadic colorectal cancer". World J. Gastroenterol. 10 (21): 3122–6. PMID 15457556.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Jiang H, Luo S, Li H (2005). "Cdk5 activator-binding protein C53 regulates apoptosis induced by genotoxic stress via modulating the G2/M DNA damage checkpoint". J. Biol. Chem. 280 (21): 20651–9. doi:10.1074/jbc.M413431200. PMID 15790566.
- Yin X, Warner DR, Roberts EA, et al. (2005). "Novel interaction between nuclear co-activator CBP and the CDK5 activator binding protein - C53". Int. J. Mol. Med. 16 (2): 251–6. doi:10.3892/ijmm.16.2.251. PMID 16012757.
- Wang J, He X, Luo Y, Yarbrough WG (2006). "A novel ARF-binding protein (LZAP) alters ARF regulation of HDM2". Biochem. J. 393 (Pt 2): 489–501. doi:10.1042/BJ20050960. PMC 1360699. PMID 16173922.
- Kim E, Chen F, Wang CC, Harrison LE (2006). "CDK5 is a novel regulatory protein in PPARgamma ligand-induced antiproliferation". Int. J. Oncol. 28 (1): 191–4. doi:10.3892/ijo.28.1.191. PMID 16327995.
- Camargo LM, Collura V, Rain JC, et al. (2007). "Disrupted in Schizophrenia 1 Interactome: evidence for the close connectivity of risk genes and a potential synaptic basis for schizophrenia". Mol. Psychiatry. 12 (1): 74–86. doi:10.1038/sj.mp.4001880. PMID 17043677.
- Ewing RM, Chu P, Elisma F, et al. (2007). "Large-scale mapping of human protein-protein interactions by mass spectrometry". Mol. Syst. Biol. 3 (1): 89. doi:10.1038/msb4100134. PMC 1847948. PMID 17353931.
- Stav D, Bar I, Sandbank J (2007). "Usefulness of CDK5RAP3, CCNB2, and RAGE genes for the diagnosis of lung adenocarcinoma". Int. J. Biol. Markers. 22 (2): 108–13. PMID 17549666.
- Wang J, An H, Mayo MW, et al. (2007). "LZAP, a putative tumor suppressor, selectively inhibits NF-kappaB". Cancer Cell. 12 (3): 239–51. doi:10.1016/j.ccr.2007.07.002. PMID 17785205.
External links
- Human CDK5RAP3 genome location and CDK5RAP3 gene details page in the UCSC Genome Browser.
This article on a gene on human chromosome 17 is a stub. You can help Wikipedia by expanding it. |